Kimberly-Clark is buying Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a massive consumer health goods company.
Breaking
BBC misleads viewers by deceptively editing Trump's January 6th speech, sparking controversy....
'CEO of several companies in Mexico, India and the United Arab Emirates ... has been able to evade enforcement authorities while continuing to profit from human smuggling and drug trafficking'...
loading...